Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NeuroPace Inc Director's Dealing 2021

Apr 23, 2021

33194_dirs_2021-04-23_90b20d43-079c-4496-9619-b42d317e9c8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21

Reporting Person: Ridley Irina (General Counsel and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-21 Common Stock P 2352 $17.00 Acquired 2352 Direct

Footnotes

F1: Reflects shares purchased from the underwriters in the Companys initial public offering.